List of Komodo Healthcare Map Customers
San Francisco, 94107, CA,
United States
Since 2010, our global team of researchers has been studying Komodo Healthcare Map customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Komodo Healthcare Map for Analytics and BI from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Komodo Healthcare Map for Analytics and BI include: Alnylam Pharmaceuticals, Inc., a United States based Life Sciences organisation with 2002 employees and revenues of $1.04 billion, Veradigm, a United States based Professional Services organisation with 2600 employees and revenues of $588.0 million, Karyopharm Therapeutics, a United States based Life Sciences organisation with 385 employees and revenues of $157.0 million, Omeros Corporation, a United States based Life Sciences organisation with 213 employees and revenues of $73.0 million, PSC Partners Seeking a Cure, a United States based Life Sciences organisation with 15 employees and revenues of $1.0 million and many others.
Contact us if you need a completed and verified list of companies using Komodo Healthcare Map, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Komodo Healthcare Map customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Alnylam Pharmaceuticals, Inc. | Life Sciences | 2002 | $1.0B | United States | Komodo Health | Komodo Healthcare Map | Analytics and BI | 2019 | n/a |
In 2019, Alnylam Pharmaceuticals, Inc. implemented Komodo Healthcare Map to support commercial analytics and go to market prioritization. The deployment targeted the Global Commercial Excellence organization and adjacent commercial functions, aligning the Komodo Healthcare Map with account prioritization and field targeting workflows for sales and commercial operations.
Komodo Healthcare Map was configured to deliver population level and patient level analytics, cohort identification, geospatial mapping, provider and specialty segmentation, and executive dashboards. The implementation emphasized interactive visualization and cohort discovery capabilities to support account-level engagement planning and commercial segmentation, with role specific dashboards provisioned for commercial leadership and field teams.
Operational coverage focused on commercial excellence and GTM planning rather than clinical R&D workflows, with the Komodo Healthcare Map used to inform territory focus, target selection, and campaign prioritization. Implementation narrative centers on analytics-driven decision support, demand shaping, and evidence based targeting for sales and market access stakeholders.
Governance changes included centralized access to Komodo Healthcare Map outputs and process adjustments for how targets are nominated and prioritized by the Global Commercial Excellence team. According to John Garcia, Global Commercial Excellence Lead, Komodo Health has really helped to focus people in the right area, and that’s been a huge boost for our organization, an explicit outcome cited by the customer.
|
 |
Karyopharm Therapeutics | Life Sciences | 385 | $157M | United States | Komodo Health | Komodo Healthcare Map | Analytics and BI | 2019 | n/a |
In 2019 Karyopharm Therapeutics implemented Komodo Healthcare Map as an Analytics and BI capability to accelerate clinical trial targeting for COVID-19 related work. Komodo Healthcare Map was deployed rapidly to provide a ground-up, real-time view that threads clinical sites, physician engagement, and patient cohorts for trial planning and outreach.
The implementation used Komodo’s real-time data to support cohort identification, provider targeting, site selection, and validation workflows, leveraging Analytics and BI functionality such as interactive visualization and rapid cohort generation. Functional emphasis was on patient-level and provider-level analytics to reach infectious disease physicians and validate targeting hypotheses, consistent with category-aligned reporting, segmentation, and operational dashboards.
Operational scope centered on Global Medical and Scientific Affairs and clinical operations, with the platform used to accelerate targeting and validation for an upcoming global clinical trial. Karyopharm reported that Komodo’s technology and rapid deployment timeline enabled faster targeting of the right physicians, and that the vendor’s support would be critical to maximize the speed and efficiency of the trial.
|
 |
Omeros Corporation | Life Sciences | 213 | $73M | United States | Komodo Health | Komodo Healthcare Map | Analytics and BI | 2018 | n/a |
In 2018, Omeros Corporation implemented Komodo Healthcare Map. The Komodo Healthcare Map deployment addressed Analytics and BI needs to accelerate commercial launch readiness, explicitly supporting sales and commercial strategy functions during a product launch period.
The implementation focused on core Analytics and BI capabilities common to real-world data platforms, including interactive cohort identification, patient-level longitudinal analytics, visualization and reporting workflows, and self-service query and analysis for commercial teams. Komodo Healthcare Map was configured to surface actionable patient and prescriber insights for go-to-market planning and sales targeting, with emphasis on speed and usability for non-technical users.
Deployment was completed in a matter of weeks rather than months, enabling rapid operational use by sales, commercial strategy, and analytics teams preparing for launch. The engagement did not list external systems integrations in source notes, so the rollout emphasized direct platform adoption and internal workflow alignment within commercial operations.
Bill Woodman, Vice President of Sales at Omeros Corporation, reported the implementation achieved in weeks what would have taken months with consultants, described the software as fast and user-friendly, and stated Komodo Healthcare Map continues to be a key part of Omeros Corporation's strategy.
|
 |
|
Life Sciences | 15 | $1M | United States | Komodo Health | Komodo Healthcare Map | Analytics and BI | 2019 | n/a |
|
|
|
|
Professional Services | 2600 | $588M | United States | Komodo Health | Komodo Healthcare Map | Analytics and BI | 2019 | n/a |
|
Buyer Intent: Companies Evaluating Komodo Healthcare Map
- Healthverity, a United States based Professional Services organization with 25 Employees
- Teach Me GIS, a United States based Education company with 20 Employees
- Hyosung Corporation, a South Korea based Manufacturing organization with 25000 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||